Conducción bajo los efectos de sustancias psicoactivascorrelación de las concentraciones en fluido oral y sangre

Referencias bibliográficas

• Jones AW. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances. Traffic Inj Prev. 2005;6:317-22.
• Rodríguez-Martos A. Guía de estrategias preventivas para redu- cir la conducción bajo los efectos del alcohol y de otras sustancias psicoactivas. Madrid: Ministerio de Sanidad y Con- sumo; 2007.
• Resolución del Consejo,de 27 de noviembre de 2003, relativa a la lucha contra el consumo de sustancias psicoactivas asociadas a los accidentes viales. Diario Oficial de la Unión Europea, 22 de abril de 2004, num. C097, p 1-3.
• Council of the European Union. UE Drug Strategy 2005-2012. 15074/04 DG HIII. Bruselas 22 de noviembre de 2004:[consultado 20-11-2011];Disponible en:http://www.emcdda.europa.eu/ html.cfm/index6790EN.html.
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2007 Selected Issue. Drugs and driving. Luxembourg: Office for Official Publications of the European Communities. 2007. [consultado 30/11/2011]. Disponible en: http://www. emcdda.europa.eu/attachements.cfm/att 44717 EN TDSI07003 ENC WEB.pdf
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Legal approaches to drug and driving.
• Segura Abad LJ. Avances en medicina forense: Toxicología forense. Rev Esc Med Leg. 2007;5:4-24.
• Mørland J, Vindenes V, Jordbru DR, Knapskog AB, Kvan E, Mathisrud G, et al. Etablering av faste grenser for pa◦ virkning av andre stoff enn alkohol, (Establishing Legislative Limits for Impairment by Other Substances Than Alcohol). Oslo: Ministry of Transport and Communications; 2010.
• Vestraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int. 2005;150:143-50.
• Crouch DJ. Oral fluid collection: The neglected variable in oral fluid testing. Forensic Sci Int. 2005;150:165-73.
• De Giovanni N, Fucci N. The state of the art on the use of oral fluid as an alternative specimen in forensic toxicology. Curr Pharm Anal. 2008;4:258-73.
• Samyn N, Vestraete AG, Van Haeren C, Kintz P. Analysis of drugs of abuse in saliva. Forensic Sci Rev. 1999;11:1-19.
• Aps JKM, Martens LC. Review: The physiology of saliva and trans- fer of drugs into saliva. Forensic Sci Int. 2005;150:119-31.
• Gallardo E, Queiroz JA. The role of alternative speci- mens in toxicological analysis. Biomed Chromatogr. 2008;22: 795-821.
• Poulsen JH. Secretion of electrolytes and water by salivary glands. En: Garrett JR, Ekström J, Anderson LC, editores. Glandular mechanisms of salivary secretion. Frontiers of oral biology. Basel: Krager; 1998. p. 55-72.
• Sphiler V. Drugs in saliva. En: Clarke′s Analysis of Drugs and Poisons. 3aed. Moffat, Osselton, Widdopd,editor. London Phar- maceutical Press;2003. p. 109.
• Rasmussen F. Salivary excretion of sulphonamides and barbitu- rates by cows and goats. Acta Pharmacol Toxicol. 1964;21:11-9.
• Matin SB, Wen SH, Karam JH. Pharmacokinetics of tolbutamide in man. Prediction by tolbutamide concentration in saliva. Clin Pharmacol Ther. 1974;16:1052-8.
• Zuidame J, Van Ginneken C. Clearance concept in salivary drug excretion. Pharm Act Helv. 1983;58:88-93.
• Schipper R, Loef A, De Groot A, Hathoorn L, Dansfield E, Van Heerde W. SELDI-TOF-MA of saliva: Methodology and pre- treatment effects. J Chrom B. 2007;847:54-63.
• Dyer KR, Wilkinson C. The detection of illicit drugs in oral fluid: another potential strategy to reduce illicit drug-related harm. Drug Alcohol Review. 2008;27:99-107.
• Pil K, Raes E, Verstraete AG. The toxicological challenges in the European research project DRUID. Forensic Sci Int. 2009;1 Supplement Series1:29-32.
• Bush DM. The US mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int. 2008;174:111-9.
• Blencowe T, Pehrsson A, Lillsunde P, Vimpari K, Horwing S, Smink B, et al. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Sci Int. 2011;208:173-9.
• Drummer OF. Drug testing in oral fluid. Clin Biochem Rev. 2006;27:147-59.
• Clarke J, Wilson JF. Proficiency testing (external quality assessment) of drug detection in oral fluid. Forensic Sci Int. 2005;150:161-4.
• Langel K, Gunnar T, Ariniemi K, Rajamäki O, Lillsunde P. Validated method for he detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl. 2011;879:859-70.
• Perrigo BJ, Peel HV, Mikhael NZ. Detection of drugs in saliva of impaired drivers. J Forensic Sci. 1984;29:185-9.
• Choo RE, Huestis MA. Oral fluid as a diagnostic tool. Clin Chem Lab Med. 2004;42:1273-86.
• Verstraete AG, Goessaert AS, Veramme J. Comparison of the drug concentrations in oral fluid by two sampling methods Varian Oral Lab and Statsure Saliva Sampler. Ann Toxicol Anal. 2011;23:133-8.
• Cone EJ, Presley L, Lehrer M, Sarter W, Smith M. Oral fluid tes- ting for drugs of abuse: Positive prevalence rates by InterceptTM immunosassay screening and GC-MS-MS confirmation and sug- gested cut-off concentration. J Anal Toxicol. 2002;25:130-6.
• Department of Health, Human Services, SAMHSA. Proposed revi- sions to mandatory guidelines for federal workplace drug testing programs. Federal Register. 2004;69:19673-732.
• Pil K, Verstraete AG. Current Development in drug testing in oral fluid. Ther Drug Monit. 2008;30:196-202.
• Concheiro M, De Castro A, Quintela O, López-Rivadulla M, Cruz A. Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence. Forensic Sci Int. 2005;150:221-6.
• Choi H, Baeck S, Kim E, Lee S, Jong H, Lee J, et al. Analysis of cannabis in oral fluid specimen by GC-MS with automatic SPE. Sci Justice. 2009;49:242-6.
• Souza DZ, Boehl PO, Comiran E, Mariotti KC, Pechansky F, Duarte P, et al. Determination of amphetamine-type stimulants in oral fluid by solid-phase microextraction and gas chromatography- mass spectrometry. Anal Chim Acta. 2011;686:67-76.
• Choi H, Baeck S, Jong M, Lee S, Choi H, Chung H. Simulta- neous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases. Forensic Sci Int. 2012;215:81-7.
• Arroyo Fernández MA, Mora Font A, Sánchez Fité M, Barbal Pagés M, Palahí Adober M. Drogas de abuso en saliva de conductores: aspectos médico-legales. Rev Esp Med Legal. 2008;34:3-10.
• Campora P, Bermejo AM, Tabernero MJ, Fernández P. Quan- titation of cocaine and its major metabolites in human saliva using gas chromatography-positive chemical ionization- mass spectrometry (GC-PCI-MS). J Anal Toxicol. 2003;27: 270-4.
• Campora P, Bermejo AM, Tabernero MJ, Fernández P. Use of gas chromatography/mass spectrometry with positive chemical ionization for the determination of opiates in human oral fluid. Rapid Commun Mass Spectrom. 2006;20:1288-92.
• Sánchez M, Arroyo A, Barbal M, Palahí M, Mora A. Cozart® Rapid Scan oral fluid drug testing system validation by GC-MS/MS analysis. Ann Toxicol Anal. 2008;20:131-6.
• Mora A, Arroyo A, Barbal M, Palahí M, Barberia E, Sánchez M. Driving under the effects of drugs of abuse: studies of oral fluid. Ann Toxicol Anal. 2009;21:197-202.
• Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA. LC-atmospheric pressure chemical ionization- MS/MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Anal Chem. 2003;75:798-804.
• Concheiro M, De Castro A, Quintela O, Cruz A, López-Rivadulla M. Development and validation of a method for the quantitation of 9-tetrahydrocannabinol in oral fluid by liquid chromato- graphy electrospray-mass spectrometry. J Chromatogr B Biomed Appl. 2004;810:319-24.
• Maurer HH. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantifica- tion in blood and oral fluid. Anal Bioanal Chem. 2005;381:110-8.
• Wood M, Laloup M, Ramirez MM, Jenkins K, Young M, Ramaekers J, et al. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci Int. 2005;150:227-32.
• Samyn N, Laloup M, De Boeck G. Bioanalytical procedures for determination of drugs of abuse in oral fluid. Anal Bioanal Chem. 2007;388:1437-53.
• Concheiro M, De Castro A, Quintela O, Cruz A, López- Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2008;391:2329-38.
• Concheiro M, De Castro A, Quintela O, Cruz A, López-Rivadulla M. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing. Forensic Sci Int. 2007;170:156-62.
• Wood M, Laloup M, Samyn N, Fernández MDR, De Bruijn EA, Maes RAA, et al. Recent applications of liquid chromatography- mass spectrometry in forensic science. J Chromatogr A. 2006;1130:3-15.
• Kadehjian L. Legal issues in oral fluid testing. Forensic Sci Int. 2005;150:151-60.
• DRUID (Driving under the Influence of Drugs, Alco- hol and Medicines) Analytical evaluation of oral fluid screening devices and preceding selection procedures. Pro- ject No. TREN-05-FP6TR-S07.61320-518404-DRUID. 2010. [consultado 20-01-2012]. Disponible en: http://www.druid- project.eu/nn 107604/Druid/EN/deliverales-list/deliverables- list-node.html? nnn=true.
• Bosker WM, Huestis MA. Oral fluid testing for Drugs of Abuse. Clinical Chemistry. 2009;55:1910-31.
• Wille SM, Samyn N, Ramirez-Fernandez M, De Boeck G. Eva- luation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers. Forensic Sci Int. 2010;198:2-6.
• Toennes SW, Kauert GF, Steinmeyer S, Moeller MR.Driving under the influence of drugs: evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005;152:149-55.
• Ministerio del Interior Presencia de alcohol, drogas y medi- camentos en conductores espan ̃oles. Informe final. 2011. [consultado 12 Abr 2012]. Disponible en: http://www.dgt.es/ was6/portal/contenidos/documentos/seguridad vial/estudios informes/informe final druid prevalencia espana.pdf
• Wille SMR, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, et al. Relationship between oral fluid and blood concentra- tions of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit. 2009;31:511-9.
• Walsh JM, De Gier JJ, Christopherson AS, Verstraete AG. Drugs and driving. Traffic Inj Prev. 2004;5:241-53.
• Cone EJ. Testing human hair for drugs of abuse. I. Individual dose and time profiles of morphine and codeine in plasma, saliva, urine and beard compared to drug-induced effects on pupils and behaviour. J Anal Toxicol. 1990;14:1-7.
• Menkes DB, Howard RC, Spears GFS, Cairns ER. Salivary THC following cannabis correlates with subjective intoxication and heart rate. Psychopharmacology. 1991;103:277-9.
• Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann NY Acad Sci. 2007;1098:51-103.
• Verstraete AG. Detection times of drugs of abuse in blood, urine and oral fluid. Ther Drug Monit. 2004;26:200-5.
• Cone EJ. Saliva testing for drug of abuse. Ann NY Acad Sci. 1993;694:91-127.
• Gjerde H, Verstraete AG. Can the prevalence of high blood drug concentrations in a population be estimated by analysing oral fluid? A study of tetrahydrocannabinol and amphetamine. Forensic Sci Int. 2010;195:153-9.
• Kato K, Hilssgrove M, Winhold L, Gurelick DA, Darwin WD, Cone EJ. Cocaine and metabolite sexcretion in saliva under stimulated and non-stimulated conditions. J Anal Toxicol. 1993;17:338-41.
• Cone EJ, Oyler J, Darwin WD. Cocaine disposition in saliva follo- wing intravenous, intranasal and smoked administration. J Anal Toxicol. 1997;21:465-75.
• Kim I, Barnes AJ, Oyler JM, Scheepers R, Joseph RE, Cone EJ, et al. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem. 2002;48:1486-96.
• Jenkins AJ, Oyler JM, Cone EJ. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol. 1997;19:359-74.
• Moolchan ET, Cone EJ, Wstedik A, Huestis MA, Preston KL. Cocaine and metabolites elimination pattern in chronic cocaine users during cessation: plasma and saliva analysis. J Anal Toxi- col. 2000;24:458-66.
• Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend. 2007;87:258-67.
• Niedbala S, Kardos K, Salamone S, Fritch D, Bromgaest M, Cone EJ. Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol. 2004;28:546-52.
• Scheppers RF, Oyler JM, Joseph RE, Cone EJ, Moolchan ET, Huestis MA. Metamphetamine and amphetamine pharmacokine- tics in oral fluid and plasma after controlled oral administration to human volunteers. Clin Chem. 2003;49:121-32.
• Gjerde H, Norman PT, Chrhistophersen AS, Morlan J. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: Estimations based on drug concentration sin oral fluid. Forensic Sci Int. 2011;210:221-7.
• Gjerde H, Mordal J, Chrhistophersen AS, Bramness JC, Morlan J. Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device. J Anal Toxicol. 2010;34:204-9.
• Verstraete AG, Raes E, editores. Rosita-2 project Final Report. Gent: Academia Press; 2006.
• Gjerde H, Verstraete A. Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: A Study of tetrahydrocannabinol and amphetamine. Forensic Sci Int. 2011;212:26-30.
• Scheidweiler KB, Kolbrich EA, Spargo TL, Cone EJ, Barnes AJ, Huestis MA. Pharmacokinetics of Cocaine and Metabolites in Human Oral Fluid and Correlation With Plasma Concen- trations After Controlled Administration. Ther Drug Monit. 2010;32:628-37.
• Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MC, De la Torre R. Oral-Fluid Testing: Promises and Pitfalls. Clin Chem. 2011;57:805-10.
• Samyn N, Verstraete AG, Van Haeren C, Kintz P. Analysis of drugs of abuse in saliva. Forensic Sci Rev. 1999;11:2-17.
• ACT Government. Drug Driving in the territory: an overview of issues and options. 2010;[consultado 27 /12/2011]. Dispo- nible en: http://www.tams.act.gov.au/ data/assets/pdf file/ 0006/186549/Drug Driving in the Territory an overview of issues and options.pdf
• Vindenes V, Lund HME, Andersen W, Gjerde H, Ikdahl SE, Christophersen, et al. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci Int. 2012, doi:101016/j.forsciint.2012.01.001.
• Kidell DA, Holland JC, Athanasolis S. Testing for drugs of abuse in saliva and sweat. J Cromatogr B. 1998;713:111-35.
• Real Decreto 1428/2003, de 21 de noviembre, por el que se aprueba el Reglamento General de Circulación. Bole- tín Oficial del Estado, 23 de diciembre de 2003, num.306, p. 45684-45748.